| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4589053
Max Phase: Preclinical
Molecular Formula: C17H19N3O2
Molecular Weight: 297.36
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: c1coc(CNc2nc3ccccc3n2CC2CCCO2)c1
Standard InChI: InChI=1S/C17H19N3O2/c1-2-8-16-15(7-1)19-17(18-11-13-5-3-9-21-13)20(16)12-14-6-4-10-22-14/h1-3,5,7-9,14H,4,6,10-12H2,(H,18,19)
Standard InChI Key: PULPFDZUVGFUEF-UHFFFAOYSA-N
Associated Targets(non-human)
Short transient receptor potential channel 5 64 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 297.36 | Molecular Weight (Monoisotopic): 297.1477 | AlogP: 3.42 | #Rotatable Bonds: 5 |
| Polar Surface Area: 52.22 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 6.44 | CX LogP: 2.84 | CX LogD: 2.80 |
| Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.78 | Np Likeness Score: -1.57 |
References
| 1. Sharma SH, Pablo JL, Montesinos MS, Greka A, Hopkins CR.. (2019) Design, synthesis and characterization of novel N-heterocyclic-1-benzyl-1H-benzo[d]imidazole-2-amines as selective TRPC5 inhibitors leading to the identification of the selective compound, AC1903., 29 (2): [PMID:30538066] [10.1016/j.bmcl.2018.12.007] |
Source
Source(1):